About Metrochem API
Metrochem API is a Healthcare company based in Hyderabad (India) founded in 2002. It operates as a pharmaceutical company manufacturing Active Pharmaceutical Ingredients (APIs), Pellets (Semi finished Formulations) and Intermediates in multi therapeutic segments. Metrochem API has raised $2.31 million across 4 funding rounds from investors including GVVP Srimannarayana, Dunnala Ram Babu and K V S S Durga. The company has 1,958 employees. Metrochem API was last valued at $13.57 million in August 2020. Its Indian entity Metrochem Api Private Limited reported revenue of ₹1,107 Cr. Metrochem API offers products and services including Potatoes and Grain Marketing. Its focus areas include Traditional Pharmaceuticals and Active Pharmaceutical Ingredients.
Company details
Metrochem API was established in 2002 in Hyderabad, India, as a pharmaceutical manufacturer focused on active pharmaceutical ingredients, semi-finished pellets, and intermediates. Production occurs across therapeutic areas such as anti-ulceratives, antifungals, antidepressants, antihypertensives, and antibacterials. Operations are supported by six manufacturing facilities and a centralized research and development laboratory. Certifications held include USFDA, GMP, ISO, COFEPRIS, and Japanese accreditation.
- Headquarters Hyderabad, India
- Employees 1,958
- Stage Minicorn
- SectorsHealthcare
- Email••••••••
- Website metroapi.com
- Social LinkedIn
- Legal Name Metrochem Api Private Limited
- Date of Incorporation 01 Jul, 2002
- Jurisdiction Hyderabad, Telangana, India
- Annual Revenue₹1,107 Cr
FY 2025 · +1% YoY
- Net Profit₹18.20 Cr
FY 2025 · 2% margin
- EBITDA₹128 Cr
FY 2025 · 12% margin
- Total Equity Funding$2.31M (USD)
in 4 rounds
- Employee Count1,958
Associated legal entities of Metrochem API
Metrochem API operates through Metrochem Api Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Metrochem Api Private Limited CIN U24239TG2002PTC039223 | Active | 01 Jul 2002 | Hyderabad, Telangana | ₹1,107 Cr | 1,958 | 7 | View details |
Products & Services of Metrochem API
Metrochem API offers a comprehensive portfolio of products and services, including Potatoes and Grain Marketing.
Farming and selling of potatoes for food and industrial uses are conducted by Metrochem
Promoting and distributing of grains from farms are handled by Metrochem
Funding Insights of Metrochem API
Metrochem API has successfully raised a total of $2.31M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $2.31M
- Total Rounds 4
- First Round $802,500
(Mar 2015)
- Investors Count 8
All 4 funding rounds of Metrochem API with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2020 | – | Angel Round | $13.57M | GVVP Srimannarayana, Dunnala Ram Babu | |
| Mar 2018 | $768,500 | Angel Round | $21.28M | Hymavati N | |
| Jan 2016 | $737,522 | Angel Round | $••••• | Hymavati N | |
| Mar 2015 | $802,500 | Angel Round | $••••• | Hymavati N |
| Date | Valuation | Stage |
|---|---|---|
| Aug 2020 | $13.57M | •••••••• |
| Mar 2018 | $21.28M | •••••••• |
| Jan 2016 | $••••• | •••••••• |
| Mar 2015 | $••••• | •••••••• |
Full valuation and stage history of Metrochem API
Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.
- All valuation points
- Stage changes
- Dates
- Exports
Verified entity values are shown only after access is granted.
Last known valuation $13.57M (Aug 2020). 8 investors in total: 0 institutional and 8 angel.
Investors in Metrochem API
Metrochem API has secured backing from 8 investors, including angel investors. Prominent investors backing the company include GVVP Srimannarayana, Dunnala Ram Babu and K V S S Durga.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
GS GVVP Srimannarayana | - | – | unknown_8e2b312a0a9649028 | - |
DR Dunnala Ram Babu | - | – | unknown_6d6a478cd121416e8 | - |
KV K V S S Durga | - | – | unknown_5d440da08e424922a | - |
NV Nandepu Venkata Surya Rao | - | – | unknown_03e461d45c7641f79 | - |
NS N Surya Prakash Rao | - | – | unknown_34121347c98a4b5ea | - |
HN Hymavati N | - | – | unknown_06752a37acf74acda | - |
NV N V V R Vijaya Lakshmi | - | – | unknown_957b9b1d39504fc4b | - |
VR Venkateswara Rao N | - | – | unknown_6cb130f1937e43619 | - |
Investor details for Metrochem API
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Metrochem Api Private Limited (Metrochem API)
Metrochem Api Private Limited is the primary company behind Metrochem API. The board of Metrochem Api Private Limited currently have 5 directors; the longest-serving is Venkateswara Rao Nandepu, appointed in 2002. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Venkateswara Rao Nandepu DIN 00092757 | Managing Director | 01 Jul 2002 | 24 yrs 3 mo | Metrochem Api Private Limited |
| Veera Venkata Rama Vijayalakshmi Nandepu DIN 00092882 | Director | 01 Oct 2004 | 22 yrs | Metrochem Api Private Limited |
| Harsha Vardhan Nandepu DIN 08604597 | Whole-time director | 15 Oct 2021 | 5 yrs | Metrochem Api Private Limited |
| Hardev Nandepu DIN 08604598 | Whole-time director | 15 Oct 2021 | 5 yrs | Metrochem Api Private Limited |
| Chandramani Panda DIN 09269531 | CFO | 22 Nov 2021 | 4 yrs 10 mo | Metrochem Api Private Limited |
People of Metrochem API
17 people are tracked at Metrochem API (7 in leadership, 10 in team); the tracked headcount is 1,958.
| Name | Role | Group |
|---|---|---|
Venkateswara Rao N | Managing Director | Leadership |
Rajesh K. | Associate Vice President | Leadership |
N. Venkateswara Rao | Managing Director | Leadership |
Anand Gharat | Vice President Marketing | Leadership |
| Chief Strategy Officer | Leadership | |
| Chief Operating Officer | Leadership | |
Pavan Kumar Nissankara Rao | Vice President | Leadership |
Surya Prakash Rao Nalla | Manufacturing, Quality Control, R&D and Project Implementation | Team |
Sapna Chauhan | Assistant Marketing Manager | Team |
Snehita Peddi | Manager | Team |
Dr. Younus Mohiuddin Mohammad Pharmd / Rph / Bcmas | Deputy Manager - Global Portfolio Management | Team |
Dr. Somashekar R Bhandya | Senior Manager Biocatalysis (group Leader) | Team |
Subbu Kakani | Global Business Development - Japan | Russia | Ukraine | Republic Of Belarus | Uzbekistan | CIS | Team |
Mandali Sirisha | Deputy Manager - Corporate Human Resources | Team |
Rama Krishna Valavala | Deputy Manager | Team |
Rudra Pardhasaradhi | Manager | Team |
Jagdish Agrahari | Sr. Manager Business Development | Team |
Complete people profiles for Metrochem API
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Metrochem API
Figures of Metrochem Api Private Limited, the primary company behind Metrochem API, for FY 2025. Revenue was ₹1,107 Cr (+1% year on year). Net profit was ₹18.20 Cr (2% margin). EBITDA was ₹128 Cr (12% margin). Revenue has grown at a compounded annual rate of -1% over three years and +8% over five years.
- ₹1,107 CrRevenue · FY 2025 · +1% YoY
- ₹18.20 CrNet profit · 2% margin
- ₹128 CrEBITDA · 12% margin
- ₹20.38 CrPaid-up capital
- 1,958Employees (provident fund records)
- -1%Revenue CAGR, 3 years
- +8%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Metrochem Api Private Limited are on its company page.
Detailed financial statements for Metrochem API
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Metrochem API
4 dated milestones of Metrochem API across 18 years, from founding to its latest funding, stage changes and deals.
- Founded Metrochem API is founded.
- Funding First funding round of $802K.
- Milestone Reaches Minicorn status.
- Funding Latest funding round, Angel Round,.
Web traffic of Metrochem API
The website of Metrochem API (metroapi.com) receives about 1.9K visits a month.
- Monthly visits1.9K
▼ 9.2% vs previous month
Top companies in Traditional Health & Nutrition
10 companies that operate in the same segment as Metrochem API (Traditional Health & Nutrition), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Manufacturer of generics formulations | 2002 | Bridgewater, New Jersey, United States | – | USD 3.02 B | 8,300 | |
Biosimilar therapeutics are developed for oncology and autoimmune diseases. | 2010 | Redwood City, California, United States | USD 143.62 M | USD 42.17 M | 228 | |
Oral solid drug delivery systems are manufactured and developed. | 1985 | Mumbai, Maharashtra, India | USD 42.49 M | USD 89.42 M | 962 | |
Ophthalmic pharmaceuticals and instruments are developed for eye care. | 1853 | Bridgewater, New Jersey, United States | – | USD 5.1 B | 13,500 | |
Generic pharmaceuticals are manufactured by Teva Pharmaceuticals. | 1901 | Petah Tikva, Central District, Israel | USD 500 M | USD 18.74 B | 51,792 | |
Generic, semi-solid, and liquid dosage forms are manufactured. | 1990 | Bengaluru, Karnataka, India | – | USD 508.93 M | 5,180 | |
Pharmaceutical products are developed and marketed globally. | 2009 | Montville, New Jersey, United States | USD 155.92 M | – | – | |
Specialty generic pharmaceuticals and APIs are manufactured and marketed. | 1983 | Mumbai, Maharashtra, India | – | USD 6.21 B | 25,870 | |
Pharmaceutical company engaged in developing, manufacturing, and marketing a diverse range of pharmaceutical formulations | 1991 | Delhi, Delhi, India | USD 367.2 M | USD 1.52 B | 21,320 | |
Generics, biosimilars, APIs, and vaccines are manufactured by Wockhardt. | 1967 | Mumbai, Maharashtra, India | – | USD 353.53 M | 3,410 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Metrochem API
Metrochem API was founded in 2002 and raised its 1st funding round 13 years after it was founded.
Metrochem API is headquartered in Hyderabad, India. It is registered at Hyderabad, Telangana, India.
Metrochem API is a funded company, having raised a total of $2.31M across 4 funding rounds to date. The company's 1st funding round was a Angel Round of $802.5K, raised on Mar 2015.
Metrochem API has 1,958 employees.
The primary company behind Metrochem API, Metrochem Api Private Limited, reported revenue of ₹1,107 Cr for FY 2025, up 1% year on year.
Metrochem API was established in 2002 in Hyderabad, India, as a pharmaceutical manufacturer focused on active pharmaceutical ingredients, semi-finished pellets, and intermediates. Production occurs across therapeutic areas such as anti-ulceratives, antifungals, antidepressants, antihypertensives, and antibacterials. Operations are supported by six manufacturing facilities and a centralized research and development laboratory. Certifications held include USFDA, GMP, ISO, COFEPRIS, and Japanese accreditation.
Metrochem API offers Potatoes and Grain Marketing.
Metrochem API has 8 investors. Key investors include GVVP Srimannarayana, Dunnala Ram Babu, K V S S Durga, Nandepu Venkata Surya Rao, and N Surya Prakash Rao.
The valuation of Metrochem API is $13.57M as of Aug 2020.
Metrochem API operates through Metrochem Api Private Limited.
The legal entities of Metrochem API currently have 6 directors, including Nalini Sadhana Ramathnaidu, Chandramani Panda, Harsha Vardhan Nandepu and others.